- Home
- STIM vs HRTX Comparison
STIM vs HRTX Comparison
Compare STIM & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- HRTX
- Stock Information
- Founded
- STIM 2003
- HRTX 1983
- Country
- STIM United States
- HRTX United States
- Employees
- STIM N/A
- HRTX N/A
- Industry
- STIM Medical/Dental Instruments
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- STIM Health Care
- HRTX Health Care
- Exchange
- STIM Nasdaq
- HRTX Nasdaq
- Market Cap
- STIM 224.8M
- HRTX 242.0M
- IPO Year
- STIM 2018
- HRTX 1987
- Fundamental
- Price
- STIM $2.73
- HRTX $1.35
- Analyst Decision
- STIM Strong Buy
- HRTX Strong Buy
- Analyst Count
- STIM 2
- HRTX 2
- Target Price
- STIM $7.00
- HRTX $4.50
- AVG Volume (30 Days)
- STIM 1.1M
- HRTX 1.5M
- Earning Date
- STIM 11-11-2025
- HRTX 11-11-2025
- Dividend Yield
- STIM N/A
- HRTX N/A
- EPS Growth
- STIM N/A
- HRTX N/A
- EPS
- STIM N/A
- HRTX N/A
- Revenue
- STIM $111,106,000.00
- HRTX $149,694,000.00
- Revenue This Year
- STIM $105.70
- HRTX $10.62
- Revenue Next Year
- STIM $11.77
- HRTX $12.99
- P/E Ratio
- STIM N/A
- HRTX N/A
- Revenue Growth
- STIM 54.17
- HRTX 9.78
- 52 Week Low
- STIM $0.52
- HRTX $1.04
- 52 Week High
- STIM $5.92
- HRTX $2.68
- Technical
- Relative Strength Index (RSI)
- STIM 40.26
- HRTX 52.70
- Support Level
- STIM $2.65
- HRTX $1.28
- Resistance Level
- STIM $3.21
- HRTX $1.38
- Average True Range (ATR)
- STIM 0.20
- HRTX 0.06
- MACD
- STIM 0.02
- HRTX 0.01
- Stochastic Oscillator
- STIM 12.70
- HRTX 74.19
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.